Preoperative intensified radiochemotherapy for rectal cancer: Experience of a single institution

International Journal of Colorectal Disease

Volumn 26, Issue 2, 2011, Pages 153-164

  Dionisi, Francesco ^a   Musio, Daniela ^a   Raffetto, Nicola ^a   Codacci Pisanelli, Giovanni ^a   Iannacone, Eva ^a   Caiazzo, Rossella ^a   Banelli, Enzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Intensified radiochemotherapy; Oxaliplatin; Rectal cancer

Indexed keywords

FLUOROURACIL; OXALIPLATIN;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; AGED; ANUS SPHINCTER; ARTICLE; BLEEDING; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; COLITIS; CONSERVATIVE TREATMENT; CONSTIPATION; CONTINUOUS INFUSION; DERMATITIS; DIARRHEA; DISEASE FREE SURVIVAL; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DYSURIA; ENTERITIS; FATIGUE; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HEART PALPITATION; HERPES SIMPLEX; HUMAN; HYPERGLYCEMIA; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MICROSURGERY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPHIL; OPEN STUDY; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARESTHESIA; PATIENT COMPLIANCE; PELVIS PAIN SYNDROME; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROCTITIS; PRURITUS; RADIATION DERMATITIS; RADIATION DOSE; RECTUM CANCER; RECTUM HEMORRHAGE; RECTUM SURGERY; RETREATMENT; SENSORY NEUROPATHY; SIDE EFFECT; SKIN TOXICITY; SKIN ULCER; THORAX PAIN; TREATMENT RESPONSE; URINARY FREQUENCY; UROGENITAL TRACT DISEASE; VOMITING; WEAKNESS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT COMPLIANCE; PREOPERATIVE CARE; RECTAL NEOPLASMS;

EID: 79951727403     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-1064-9     Document Type: Article

References (55)

1. Heald RJ, Husband EM, Rtall RDH et al (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479-1482 (Pubitemid 16095660)
2. Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Dutch colorectal cancer group: preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
3. Gerard A, Buyse M, Nordiinger B et al (1988) Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 208(5):606-614
4. Thomas PR, Lindblad AS (1988) Adjuvant postoperative radiotherapy in rectal carcinoma: a review of the gastrointestinal tumour study group experience. Radiother Oncol 13(4):245-252 (Pubitemid 19009239)
5. Gerard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Orthod 24:4620-4624
6. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123 (Pubitemid 44394918)
7. Sauer R, Becker H, Hohenberger W, For the German Rectal Cancer Study Group et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1741
8. Collette L, Bosset JF, Den DulkMet al (2007) European organisation for research and treatment of cancer radiation oncology group. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? a trial of the European organisation for research and treatment of cancer radiation oncology group. J Clin Orthod 1(25(28)):4379-4386
9. Hartley A, Ho KF, McConkey C et al (2005) Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol 78:9334-9338
10. Capirci C, Valentini V, Cionini L et al (2008) Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 72:99-107
11. Andrè T, Boni C, Boudiaf-Mounedji L et al (2004) Oxaliplatin, fluoruracil and leucovorin as adjuvant treatment for rectal cancer. N Engl J Med 350:2343-235
12. Espinosa M, Martinez M, Aguilar JL et al (2005) Oxaliplatin activity in head and neck cancer cell lines cancer chemother. Pharmacol 55:301-305 (Pubitemid 40142896)
13. Cividalli A, Ceciarelli F, Livdi E et al (2002) Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int J Radiat Oncol Biol Phys 52(4):1092-1098 (Pubitemid 34219031)
14. Hermann RM, Rave-Frank M, Pradier O (2006) Combining radiation with oxaliplatin: a review of experimental results. Cancer Radiothér 12:61-67
15. Kjellstrom J, Kjellen E, Johnsson A (2005) In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line. Acta Oncol 44:687-693
16. Ryan DP, Niedzwiecki D, Hollis D (2006) Phase I-II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: cancer and leukaemia Group B 89901. J Clin Oncol 24:2557-2562 (Pubitemid 46630634)
17. Aschele C, Friso ML, Pucciarelli S et al (2005) A phase I-II study of weekly oxaliplatin, 5-fluoruracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 16:1140-1146 (Pubitemid 41418317)
18. Rödel C, Liersch T, Hermann RM et al (2007) Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 25:110-117 (Pubitemid 350003058)
19. Dionisi F, Musio D, Spinelli GP et al (2009) Preoperative radiochemotherapy of rectal cancer: toxicity and preliminary results with the addition of weekly oxaliplatin. In: Banetti E et al (eds) Platinum and other heavy metal compounds in cancer chemotherapy Humana press. Springer, Berlin, pp 295-305
20. Glynne-Jones R, Mawdsley S, Pearce T et al (2006) Alternative clinical end-points in rectal cancer: are we getting closer? Ann Oncol 17:1239-1248
21. Cancer Therapy Evaluation Program (2006) Common Terminology Criteria for Adverse Events, Version 3.0. http://ctep.cancer.gov, publish date: August 9, 2006
22. Kim JS, Kim JS, Cho MJ, Song KS et al (2002) Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 54:403-408
23. Benson A (2007) New approaches to assessing and treating earlystage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease. Clin Cancer Res 13(22S):6913-6918
24. Machiels JP, Duck L, Honhon B et al (2005) Phase II study of preoperative oxaliplatin, capecitabine and external beam radiation in patient with rectal cancer: the radiooxcape study. Ann Oncol 16:1898-1905 (Pubitemid 41724278)
25. Gerard JP, Chapet O, Nemoz C et al (2003) Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Orthod 21:1119-1124 (Pubitemid 46594142)
26. Rosenthal DI, Catalano PJ, Haller DG et al (2008) Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297. Int J Radiat Oncol Biol Phys 1 (72(1)):108-113
27. Sebag-Montefiore D, Glynne-Jones R, Falk S et al (2005) A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study. Br J Cancer 93(9):993-998 (Pubitemid 41548392)
28. Keam SJ, Dunn CJ, Figgitt DP (2005) Oxaliplatin: in operable rectal cancer. Drugs 65:89-96
29. Saif MW, Shah MM, Shah AR (2009) Fluoropyrimidine-associated cardiotoxicity: revisited. Expert Opin Drug Saf 8 (2):191-202
30. Chau I, Brown G, Cunningham D et al (2006) Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor risk rectal cancer. J Clin Oncol 24:668-673
31. Ng M, Cunningham A, Norman RA (2005) The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC). Eur J Can 41:1542-1546 (Pubitemid 40981835)
32. Rodel C, Sauer R (2007) Integration of novel agents into combined-modality treatment for rectal cancer patients. Strahlenther Onkol 183:227-235 (Pubitemid 46725993)
33. Debucquoy A, Libbrecht L, Roubrock V et al (2008) Morphological features and molecular markers in rectal cancer from 95 patients included in the European organisation for research and treatment of cancer 22921 trial: Prognostic value and effects of preoperative radio (chemo) therapy. Eur J Can 44:791-797
34. Schaffzin DM, Wong WD (2004) Endorectal ultrasound in the preoperative evaluation of rectal cancer. Clin Colorectal Cancer 4:124-132 (Pubitemid 39199252)
35. Carlomagno C, Farella A, Bucci L et al (2009) Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study. Ann Oncol 20:906-912
36. Janjan AN, Abbruzzese J, Pazdur R et al (1999) Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 51:153-160 (Pubitemid 29320309)
37. Ben-Josef E (2007) Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer. Am J Clin Oncol 30(6):649-655
38. Valentini V, Coco C, Picciocchi A et al (2002) Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53:664-674 (Pubitemid 34626505)
39. Kaminsky-Forrett MC, Conroy T, Luporsi E et al (1998) Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 42:935-941 (Pubitemid 29004132)
40. Kim KN, Bayk HS, Seong JS et al (2006) Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer. Ann Surg 244(6):1024-1030
41. Lezoche G, Baldarelli M, Guerrieri M (2008) A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versuslaparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 22(2):352-358
42. Bujko K, Richter P, Kolodziejczyk M et al (2009) Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders. Radiother Oncol 92:195-201
43. Osti MF, Valeriani M, Masoni L et al (2004) Neoadjuvant chemoradiation for locally advanced carcinoma of the rectum. Tumori 90:303-309 (Pubitemid 38981277)
44. Gambacorta MA, Valentini V, Coco C et al (2007) Sphincter preservation in four consecutive phase II studies of preoperative chemoradiation: analysis of 247 T3 rectal cancer patients. Tumori 93(2):160-169 (Pubitemid 46866706)
45. Baxter NN, Garcia-Aguilar J (2007) Organ preservation for rectal cancer. J Clin Oncol 25(8):1014-1020 (Pubitemid 350002869)
46. Mohiuddin M, Mohiuddin MM, Marks J (2009) Future directions in neoadjuvant therapy of rectal cancer: maximizing pathological complete response rates. Cancer Treat Rev 35(7):547-552
47. Kuo LJ, Liu MC, Jer-Min Jian J et al (2007) Is Final TNM Staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 14 (10):2766-2772
48. Das P, Skibber MJ, Rodriguez-Bigas AM et al (2007) Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109 (9):1750-1755 (Pubitemid 46668536)
49. Habr-Gama A, Perez RO, Nadalin Wet al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711-718 (Pubitemid 39281293)
50. Aschele C, Pinto C, Cordio S et al (2009) Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial. J Clin Oncol 27:18s
51. Gerard JP, Azria D, Gourgou-Bourgade S et al (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer. Results of the phase II trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638-1644
52. Tepper JE, Wang ZA (2010) Improving local control in rectal cancer: radiation sensitizers or radiation dose? J Clin Oncol 28:1623-1624
53. Hospers AG, Punt JAC, Tesselaar EM et al (2007) Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the dutch colorectal cancer group. Ann Surg Oncol 14(10):2773-2779
54. Gambacorta MA, Valentini V, Coco C et al (2004) Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: phase I and II studies. Int J Radiat Oncol Biol Phys 60(1):139-148 (Pubitemid 39165478)
55. FakihGM, Rajput A,Yang GYet al (2006) Aphase I study ofweekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 65(5):1462-1470